Skip to main content
Top
Published in: BMC Medical Genetics 1/2010

Open Access 01-12-2010 | Research article

SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10and PAD in type 2 diabetes

Authors: Yi-Der Jiang, Yi-Cheng Chang, Yen-Feng Chiu, Tien-Jyun Chang, Hung-Yuan Li, Wen-Hsing Lin, Hsiang-Yu Yuan, Yuan-Tsong Chen, Lee-Ming Chuang

Published in: BMC Medical Genetics | Issue 1/2010

Login to get access

Abstract

Background

Recent data indicate that loss-of-function mutation in the gene encoding the facilitative glucose transporter GLUT10 (SLC2A10) causes arterial tortuosity syndrome via upregulation of the TGF-β pathway in the arterial wall, a mechanism possibly causing vascular changes in diabetes.

Methods

We genotyped 10 single nucleotide polymorphisms and one microsatellite spanning 34 kb across the SLC2A10 gene in a prospective cohort of 372 diabetic patients. Their association with the development of peripheral arterial disease (PAD) in type 2 diabetic patients was analyzed.

Results

At baseline, several common SNPs of SLC2A10 gene were associated with PAD in type 2 diabetic patients. A common haplotype was associated with higher risk of PAD in type 2 diabetic patients (haplotype frequency: 6.3%, P = 0.03; odds ratio [OR]: 14.5; 95% confidence interval [CI]: 1.3- 160.7) at baseline. Over an average follow-up period of 5.7 years, carriers with the risk-conferring haplotype were more likely to develop PAD (P = 0.007; hazard ratio: 6.78; 95% CI: 1.66- 27.6) than were non-carriers. These associations remained significant after adjustment for other risk factors of PAD.

Conclusion

Our data demonstrate that genetic polymorphism of the SLC2A10 gene is an independent risk factor for PAD in type 2 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR: UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002, 25: 894-899. 10.2337/diacare.25.5.894.CrossRefPubMed Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR: UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002, 25: 894-899. 10.2337/diacare.25.5.894.CrossRefPubMed
2.
go back to reference Keen H, Clark C, Laakso M: Reducing the burden of diabetes: managing cardiovascular disease. Diabetes Metab Res Rev. 1999, 15: 186-196. 10.1002/(SICI)1520-7560(199905/06)15:3<186::AID-DMRR30>3.0.CO;2-5.CrossRefPubMed Keen H, Clark C, Laakso M: Reducing the burden of diabetes: managing cardiovascular disease. Diabetes Metab Res Rev. 1999, 15: 186-196. 10.1002/(SICI)1520-7560(199905/06)15:3<186::AID-DMRR30>3.0.CO;2-5.CrossRefPubMed
3.
go back to reference Carmelli D, Fabsitz RR, Swan GE, Reed T, Miller B, Wolf PA: Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute. Am J Epidemiol. 2000, 151: 452-458.CrossRefPubMed Carmelli D, Fabsitz RR, Swan GE, Reed T, Miller B, Wolf PA: Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute. Am J Epidemiol. 2000, 151: 452-458.CrossRefPubMed
4.
go back to reference Gudmundsson G, Matthiasson SE, Arason H, Johannsson H, Runarsson F, Bjarnason H, et al: Localization of a Gene for Peripheral Arterial Occlusive Disease to Chromosome 1p31. Am J Hum Genet. 2002, 70: 586-592. 10.1086/339251.CrossRefPubMedPubMedCentral Gudmundsson G, Matthiasson SE, Arason H, Johannsson H, Runarsson F, Bjarnason H, et al: Localization of a Gene for Peripheral Arterial Occlusive Disease to Chromosome 1p31. Am J Hum Genet. 2002, 70: 586-592. 10.1086/339251.CrossRefPubMedPubMedCentral
5.
go back to reference Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al: Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006, 38: 452-457. 10.1038/ng1764.CrossRefPubMed Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al: Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006, 38: 452-457. 10.1038/ng1764.CrossRefPubMed
6.
go back to reference Drera B, Guala A, Zoppi N, Gardella R, Franceschini P, Barlati S, et al: Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome. Am J Med Genet A. 2007, 143: 216-218.CrossRef Drera B, Guala A, Zoppi N, Gardella R, Franceschini P, Barlati S, et al: Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome. Am J Med Genet A. 2007, 143: 216-218.CrossRef
7.
go back to reference Zaidi SH, Meyer S, Peltekova VD, Lindinger A, Teebi AS, Faiyaz-Ul-Haque M: A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin. Eur J Pediatr. 2008. Zaidi SH, Meyer S, Peltekova VD, Lindinger A, Teebi AS, Faiyaz-Ul-Haque M: A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin. Eur J Pediatr. 2008.
8.
go back to reference Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, et al: Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat. 2008, 29: 150-158. 10.1002/humu.20623.CrossRefPubMed Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, et al: Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat. 2008, 29: 150-158. 10.1002/humu.20623.CrossRefPubMed
9.
go back to reference Brownlee M: The Pathobiology of Diabetic Complications. A Unifying Mechanism. Diabetes. 2005, 54: 1615-1625. 10.2337/diabetes.54.6.1615.CrossRefPubMed Brownlee M: The Pathobiology of Diabetic Complications. A Unifying Mechanism. Diabetes. 2005, 54: 1615-1625. 10.2337/diabetes.54.6.1615.CrossRefPubMed
10.
go back to reference Ziyadeh FN: Mediators of Diabetic Renal Disease: The case for TGF-β as the major mediator. J Am Soc Nephrol. 2004, 15: S55-S57. 10.1097/01.ASN.0000093460.24823.5B.CrossRefPubMed Ziyadeh FN: Mediators of Diabetic Renal Disease: The case for TGF-β as the major mediator. J Am Soc Nephrol. 2004, 15: S55-S57. 10.1097/01.ASN.0000093460.24823.5B.CrossRefPubMed
11.
go back to reference Chiarelli F, Santilli F, Mohn A: Role of growth factors in the development of diabetic complications. Hormone Research. 2000, 53: 53-67. 10.1159/000023515.CrossRefPubMed Chiarelli F, Santilli F, Mohn A: Role of growth factors in the development of diabetic complications. Hormone Research. 2000, 53: 53-67. 10.1159/000023515.CrossRefPubMed
12.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
13.
go back to reference Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al: ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006, 47: 1239-1312. 10.1016/j.jacc.2005.10.009.CrossRefPubMed Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al: ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006, 47: 1239-1312. 10.1016/j.jacc.2005.10.009.CrossRefPubMed
14.
go back to reference Lin WH, Chuang LM, Chen CH, Yeh JI, Hsieh PS, Cheng CH, et al: An association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in Taiwanese population. Diabetologia. 2006, 49: 1214-1221. 10.1007/s00125-006-0218-3.CrossRefPubMed Lin WH, Chuang LM, Chen CH, Yeh JI, Hsieh PS, Cheng CH, et al: An association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in Taiwanese population. Diabetologia. 2006, 49: 1214-1221. 10.1007/s00125-006-0218-3.CrossRefPubMed
15.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed
16.
go back to reference Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002, 70: 425-434. 10.1086/338688.CrossRefPubMed Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002, 70: 425-434. 10.1086/338688.CrossRefPubMed
17.
go back to reference Mueckler M: Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Diabetes. 1990, 39: 6-11. 10.2337/diabetes.39.1.6.CrossRefPubMed Mueckler M: Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Diabetes. 1990, 39: 6-11. 10.2337/diabetes.39.1.6.CrossRefPubMed
18.
go back to reference Cheng CH, Kikuchi T, Chen YH, Sabbagha NG, Lee YC, Pan HJ, et al: Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc Res. 2008. Cheng CH, Kikuchi T, Chen YH, Sabbagha NG, Lee YC, Pan HJ, et al: Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc Res. 2008.
19.
go back to reference Andersen G, Rose CS, Hamid YH, Drivsholm T, Borch-Johnsen K, Pedersen O: Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationship to type 2 diabetes and intermediary traits. Diabetes. 2003, 52: 2445-2448. 10.2337/diabetes.52.9.2445.CrossRefPubMed Andersen G, Rose CS, Hamid YH, Drivsholm T, Borch-Johnsen K, Pedersen O: Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationship to type 2 diabetes and intermediary traits. Diabetes. 2003, 52: 2445-2448. 10.2337/diabetes.52.9.2445.CrossRefPubMed
20.
go back to reference Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, et al: Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature. 2005, 434: 338-345. 10.1038/nature03441.CrossRefPubMedPubMedCentral Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, et al: Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature. 2005, 434: 338-345. 10.1038/nature03441.CrossRefPubMedPubMedCentral
21.
go back to reference Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M: Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001, 44 (Suppl 2): S65-71. 10.1007/PL00002941.CrossRefPubMed Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M: Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001, 44 (Suppl 2): S65-71. 10.1007/PL00002941.CrossRefPubMed
22.
go back to reference Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995, 38: 86-96. 10.1007/BF02369357.CrossRefPubMed Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995, 38: 86-96. 10.1007/BF02369357.CrossRefPubMed
23.
go back to reference Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V: Prevalence and risk factors of peripheral vascular disease in a selected south India population. Diabetes Care. 2000, 23: 1295-1300. 10.2337/diacare.23.9.1295.CrossRefPubMed Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V: Prevalence and risk factors of peripheral vascular disease in a selected south India population. Diabetes Care. 2000, 23: 1295-1300. 10.2337/diacare.23.9.1295.CrossRefPubMed
24.
go back to reference The International HapMap Consortium: The International HapMap Project. Nature. 2003, 426: 789-796. 10.1038/nature02168.CrossRef The International HapMap Consortium: The International HapMap Project. Nature. 2003, 426: 789-796. 10.1038/nature02168.CrossRef
25.
go back to reference Yang HC, Lin CH, Hsu CL, Hung SI, Wu JY, Pen WH, Chen YT, Fann CS: A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci. 2006, 13: 489-98. 10.1007/s11373-006-9077-7.CrossRefPubMed Yang HC, Lin CH, Hsu CL, Hung SI, Wu JY, Pen WH, Chen YT, Fann CS: A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci. 2006, 13: 489-98. 10.1007/s11373-006-9077-7.CrossRefPubMed
Metadata
Title
SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10and PAD in type 2 diabetes
Authors
Yi-Der Jiang
Yi-Cheng Chang
Yen-Feng Chiu
Tien-Jyun Chang
Hung-Yuan Li
Wen-Hsing Lin
Hsiang-Yu Yuan
Yuan-Tsong Chen
Lee-Ming Chuang
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2010
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-11-126

Other articles of this Issue 1/2010

BMC Medical Genetics 1/2010 Go to the issue